We use cookies for a better user experience. Read our Privacy Policy

I Agree

Blood Transfusion Diagnostics Market

Blood Transfusion Diagnostics Market (Product Type - Instruments and Kits, Reagents; Application - Blood Grouping, Disease Screening (Molecular Disease Screening, Serological Disease Screening); End use - Hospitals, Diagnostic Laboratories, Blood Banks, Plasma Fractionation Companies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Blood Transfusion Diagnostics Market - Snapshot

Blood transfusion diagnostics are products used to conduct tests before transfusion of blood and blood products from donor to recipient. These products include instruments such as analyzers and centrifuges, and kits & reagents for various tests such as blood grouping and disease screening for donors as well as patients. Blood screening is a major step in the pre-transfusion process. Various instruments, test kits, and reagents based on molecular and serological techniques are used to detect transfusion transmitted infections (TTIs) along with establishing the compatibility of donor and patient blood group before transfusion. The global blood transfusion diagnostics market was valued at US$ 3.0 Bn in 2016 and is projected to expand at a CAGR of 5.9% from 2017 to 2025 to reach US$ 5.5 Bn by 2025.

Increase in shift toward automation in blood banks is likely to benefit blood collection facilities due to reduced turnaround time for test completion and overcoming the shortage of workforce required to conduct the requisite tests. Deployment of automated systems is anticipated to help these facilities to reorganize workflow and increase efficiency. Rise in demand for blood and blood components transfusions owing to large patient population suffering from chronic diseases such as aplastic anemia, sickle cell anemia, and leukemia is the major factor driving the blood transfusion diagnostics market. According to estimates provided by the American Cancer Society, nearly 62,130 new cases of leukemia were reported in the U.S. alone in 2017. According to Centers for Disease Control and Prevention (CDC) estimates, 100,000 people are affected by sickle cell disease in the U.S. each year. Rise in incidence of chronic diseases presents large patient population requiring blood transfusions. This is expected to drive demand for blood transfusions, leading to increase in demand for transfusion diagnostic instruments, kits, and reagents.

global blood transfusion diagnostics market

There is a shift toward automation of instruments, multiplexing assays, and new techniques for blood grouping and disease screening, delivering high throughput results with reduced turnaround time, and enabling health care providers to analyze multiple samples in short time. In February 2017, Immucor, Inc. announced the launch of MIA FORA NGS FLEX HLA Typing Assay, a new molecular test for blood typing. Increase in government initiatives and implementation of policies regarding blood safety and availability are anticipated to drive demand and consumption of blood transfusion diagnostic test instruments and kits, which in turn is likely to propel the market during the forecast period. In September 2017, the Ministry of Health of Saudi Arabia launched a national campaign named My Blood for My Country along with various protocols for blood transfusion diagnostics in the country. However, shortage of highly skilled technologists for blood transfusion services and decline in blood donation rates across the globe are likely to hamper the growth of the market. Nevertheless, burgeoning needs of blood banks for plasma testing of recovered plasma for infectious disease screening offers significant opportunity for players operating in the global blood transfusion diagnostic market for developing new tests and assays for plasma testing.

The global blood transfusion diagnostics market has been segmented based on product type, application, end-user, and region. In terms of product type, the kits & reagents segment is anticipated to account for major market share, followed by the instruments segment. Increase in blood donations and rise in number of blood transfusion procedures globally are factors contributing to the high consumption of kits & reagents for blood transfusion diagnostics. Based on application, the disease screening segment accounted for the largest market share in 2016 and is expected to gain market share by 2025. Increase in emphasis on disease screening tests owing to rise in incidence of transfusion transmitted infections is likely to augment the segment from 2017 to 2025. In terms of end-user, the blood banks segment held the dominant share in terms of revenue in 2016. The segment is projected to maintain its lead over the other segments during the forecast period. Increase in number of blood banks and blood centers globally is expected to fuel the growth of the market.

Geographically, North America was the leading market in terms of revenue due to high percentage of active and voluntary blood donors in countries such as the U.S. and Canada, increase in number of blood transfusions per year, and various blood transfusion policies being implemented regarding safety and testing of blood for infectious diseases. The market in Asia Pacific is projected to grow at a rapid pace during the forecast period, owing to large patient pool requiring blood transfusions and rise in awareness about disease screening in countries in the region.

Major players in the global blood transfusion diagnostics market include BAG Health Care GmbH, Abbott Laboratories, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., DiaSorin S.p.A., Grifols, S.A., Immucor, Inc., Hologic, Inc., Ortho Clinical Diagnostics, and Quotient Limited.

Rising Demand for Donor Screening Motivates Growth in Blood Transfusion Diagnostics Market

Increasing prevalence of chronic diseases as well as the rising demand for donor screening are couple of most prominent factors influencing growth in the global blood transfusion diagnostics market. Increase in the prevalence of various chronic diseases, including anemia, hemophilia, liver disease, sickle cell disease, thrombocytopenia, cancer, kidney diseases, and severe infections have all led to increased demand in the global blood transfusion diagnostics market. Among these, anemia, one of the most common blood disorders is caused by deficiency of iron in human blood. This requires transfusion of red blood cells, hence leading to an increased demand for products in the global blood transfusion diagnostics market.

Furthermore, rising awareness regarding the blood transfusion diagnosis in order to prevent hazardous blood borne diseases and infection, as well as fast paced shift toward automation and mechanization of blood and blood component storage banks are stimulating the growth trajectory in global blood transfusion diagnostics market. The pandemic situation created by the outbreak of novel corona virus has also presented the global blood transfusion diagnostics market with numerous growth opportunities. For example, there were multiple plasma transfusion trials conducted in the United States.

However, the pandemic also created certain challenges for the global blood transfusion diagnostics market. Some of the key challenges faced by the players in global blood transfusion diagnostics market over the pandemic include diminished donor inflow, shortage of blood units, rising concerns pertaining to transfusion transmitted corona virus, and dearth of skilled professional staff. However, since the debarring of social restrictions, there has been considerable increase in the blood transfusion and blood donation procedures all over the world. This trend is favoring the development of the global blood transfusion diagnostics market.

Shift of various industry players towards Molecular Automated Platforms is also another significant driver for the global blood transfusion diagnostics market in recent times. Introduction of these automated molecular platforms is bolstering the shift from manual instruments and tests towards semi as well as fully automated testing instruments. This has resulted in fast detection of transfusion transmissible infections as well as in eliminating human error during transfusion procedures.

The global blood transfusion diagnostics market has been segmented as follows:

Product

  • Instruments
  • Kits & Reagents

Application

  • Blood Grouping
  • Disease Screening
    • Molecular Disease Screening
    • Serological Disease Screening

End-user

  • Hospitals
  • Diagnostic Laboratories
  • Blood Banks
  • Plasma Fractionation Companies
  • Others

Region

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Rest of MEA
Blood Transfusion Diagnostics Market

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

1. Preface
     1.1. Market Definition and Scope
     1.2. Market Segmentation
     1.3. Key Research Objectives
     1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Blood Transfusion Diagnostics Market

4. Market Overview
     4.1. Introduction
            4.1.1. Product Type Definition
            4.1.2. Industry Evolution / Developments
     4.2. Overview
     4.3. Market Dynamics
            4.3.1. Drivers
            4.3.2. Restraints
            4.3.3. Opportunities
     4.4. Global Blood Transfusion Diagnostics Market Analysis and Forecasts, 2015–2025
            4.4.1. Market Revenue Projections (US$ Mn)
     4.5. Porter’s Five Force Analysis

5. Spend For Plasma Testing For Infectious Diseases (US$ Mn), by Plasma Fractionation Companies, 2015

6. Global Blood Transfusion Diagnostics Market Analysis and Forecasts, by Product Type
     6.1. Introduction & Definition
     6.2. Key Findings / Developments
     6.3. Market Value Forecast, by Product Type, 2015–2025
            6.3.1. Instruments
            6.3.2. Kits & Reagents
     6.4. Market Attractiveness, by Product Type

7. Global Blood Transfusion Diagnostics Market Analysis and Forecasts, by Application
     7.1. Introduction & Definition
     7.2. Key Findings / Developments
     7.3. Market Value Forecast, by Application, 2015–2025
            7.3.1. Blood Grouping
            7.3.2. Disease Screening
                     7.3.2.1. Serological Disease Screening
                     7.3.2.2. Molecular Disease Screening
     7.4. Market Attractiveness, by Application

8. Global Blood Transfusion Diagnostics Market Analysis and Forecasts, by End-user
     8.1. Introduction & Definition
     8.2. Key Findings / Developments
     8.3. Market Value Forecast, by End-user, 2015–2025
            8.3.1. Hospitals
            8.3.2. Blood Banks
            8.3.3. Diagnostic Laboratories
            8.3.4. Plasma Fractionation Companies
            8.3.5. Others
     8.4. Market Attractiveness, by End-user

9. Global Blood Transfusion Diagnostics Market Analysis and Forecasts, by Region
     9.1. Key Findings
     9.2. Market Value Forecast, by Region
            9.2.1. North America
            9.2.2. Europe
            9.2.3. Asia Pacific
            9.2.4. Latin America
            9.2.5. Middle East & Africa
     9.3. Market Attractiveness, by Region

10. North America Blood Transfusion Diagnostics Market Analysis and Forecast
     10.1. Introduction
            10.1.1. Key Findings
     10.2. Market Value Forecast, by Product Type, 2015–2025
            10.2.1. Instruments
            10.2.2. Kits & Reagents
     10.3. Market Value Forecast, by Application, 2015–2025
            10.3.1. Blood Grouping
            10.3.2. Disease Screening
                     10.3.2.1. Serological Disease Screening
                     10.3.2.2. Molecular Disease Screening
     10.4. Market Value Forecast, by End-user, 2015–2025
            10.4.1. Hospitals
            10.4.2. Blood Banks
            10.4.3. Diagnostic Laboratories
            10.4.4. Plasma Fractionation Companies
            10.4.5. Others
     10.5. Market Value Forecast, by Country, 2015–2025
            10.5.1. U.S.
            10.5.2. Canada
     10.6. Market Attractiveness Analysis
            10.6.1. By Product Type
            10.6.2. By Application
            10.6.3. By End-user
            10.6.4. By Country

11. Europe Blood Transfusion Diagnostics Market Analysis and Forecast
     11.1. Introduction
            11.1.1. Key Findings
     11.2. Market Value Forecast, by Product Type, 2015–2025
            11.2.1. Instruments
            11.2.2. Kits & Reagents
     11.3. Market Value Forecast, by Application, 2015–2025
            11.3.1. Blood Grouping
            11.3.2. Disease Screening
                     11.3.2.1. Serological Disease Screening
                     11.3.2.2. Molecular Disease Screening
     11.4. Market Value Forecast, by End-user, 2015–2025
            11.4.1. Hospitals
            11.4.2. Blood Banks
            11.4.3. Diagnostic Laboratories
            11.4.4. Plasma Fractionation Companies
            11.4.5. Others
     11.5. Market Value Forecast, by Country/Sub-region, 2015–2025
            11.5.1. Germany
            11.5.2. U.K.
            11.5.3. France
            11.5.4. Spain
            11.5.5. Italy
            11.5.6. Rest of Europe
     11.6. Market Attractiveness Analysis
            11.6.1. By Product Type
            11.6.2. By Application
            11.6.3. By End-user
            11.6.4. By Country/Sub-region

12. Asia Pacific Blood Transfusion Diagnostics Market Analysis and Forecast
     12.1. Introduction
            12.1.1. Key Findings
     12.2. Market Value Forecast, by Product Type, 2015–2025
            12.2.1. Instruments
            12.2.2. Kits & Reagents
     12.3. Market Value Forecast, by Application, 2015–2025
            12.3.1. Blood Grouping
            12.3.2. Disease Screening
                     12.3.2.1. Serological Disease Screening
                     12.3.2.2. Molecular Disease Screening
     12.4. Market Value Forecast, by End-user, 2015–2025
            12.4.1. Hospitals
            12.4.2. Blood Banks
            12.4.3. Diagnostic Laboratories
            12.4.4. Plasma Fractionation Companies
            12.4.5. Others
     12.5. Market Value Forecast, by Country/Sub-region, 2015–2025
            12.5.1. China
            12.5.2. Japan
            12.5.3. India
            12.5.4. Rest of Asia Pacific
     12.6. Market Attractiveness Analysis
            12.6.1. By Product Type
            12.6.2. By Application
            12.6.3. By End-user
            12.6.4. By Country/Sub-region

13. Latin America Blood Transfusion Diagnostics Market Analysis and Forecast
     13.1. Introduction
            13.1.1. Key Findings
     13.2. Market Value Forecast, by Product Type, 2015–2025
            13.2.1. Instruments
            13.2.2. Kits & Reagents
     13.3. Market Value Forecast, by Application, 2015–2025
            13.3.1. Blood Grouping
            13.3.2. Disease Screening
                     13.3.2.1. Serological Disease Screening
                     13.3.2.2. Molecular Disease Screening
     13.4. Market Value Forecast, by End-user, 2015–2025
            13.4.1. Hospitals
            13.4.2. Blood Banks
            13.4.3. Diagnostic Laboratories
            13.4.4. Plasma Fractionation Companies
            13.4.5. Others
     13.5. Market Value Forecast, by Country/Sub-region, 2015–2025
            13.5.1. Brazil
            13.5.2. Mexico
            13.5.3. Rest of Latin America
     13.6. Market Attractiveness Analysis
            13.6.1. By Product Type
            13.6.2. By Application
            13.6.3. By End-user
            13.6.4. By Country/Sub-region

14. Middle East & Africa Blood Transfusion Diagnostics Market Analysis and Forecast
     14.1. Introduction
            14.1.1. Key Findings
     14.2. Market Value Forecast, by Product Type, 2015–2025
            14.2.1. Instruments
            14.2.2. Kits & Reagents
     14.3. Market Value Forecast, by Application, 2015–2025
            14.3.1. Blood Grouping
            14.3.2. Disease Screening
                     14.3.2.1. Serological Disease Screening
                     14.3.2.2. Molecular Disease Screening
     14.4. Market Value Forecast, by End-user, 2015–2025
            14.4.1. Hospitals
            14.4.2. Blood Banks
            14.4.3. Diagnostic Laboratories
            14.4.4. Plasma Fractionation Companies
            14.4.5. Others
     14.5. Market Value Forecast, by Country/Sub-region, 2015–2025
            14.5.1. Saudi Arabia
            14.5.2. South Africa
            14.5.3. Rest of Middle East & Africa
     14.6. Market Attractiveness Analysis
            14.6.1. By Product Type
            14.6.2. By Application
            14.6.3. By End-user
            14.6.4. By Country/Sub-region

15. Company Profiles
     15.1. Market Player - Competition Matrix (By Tier and Size of companies)
     15.2. Market Share Analysis, by Company, 2017 (estimated)
     15.3 Company Profiles
            15.3.1 Grifols S.A.
                     15.3.1.1 Company Details
                     15.3.1.2 Business Overview
                     15.3.1.3 Financial Overview
                     15.3.1.4 Strategic Overview
                     15.3.1.5 SWOT Analysis
            15.3.2 Immucor, Inc.
                     15.3.2.1 Company Details
                     15.3.2.2 Business Overview
                     15.3.2.3 Financial Overview
                     15.3.2.4 Strategic Overview
                     15.3.2.5 SWOT Analysis
            15.3.3 Ortho Clinical Diagnostics
                     15.3.3.1 Company Details
                     15.3.3.2 Business Overview
                     15.3.3.3 Financial Overview
                     15.3.3.4 Strategic Overview
                     15.3.3.5 SWOT Analysis
            15.3.4 Abbott
                     15.3.4.1 Company Details
                     15.3.4.2 Business Overview
                     15.3.4.3 Financial Overview
                     15.3.4.4 Strategic Overview
                     15.3.4.5 SWOT Analysis
            15.3.5 Bio-Rad Laboratories, Inc.
                     15.3.5.1 Company Details
                     15.3.5.2 Business Overview
                     15.3.5.3 Financial Overview
                     15.3.5.4 Strategic Overview
                     15.3.5.5 SWOT Analysis
            15.3.6 F. Hoffman-La Roche Ltd.
                     15.3.6.1 Company Details
                     15.3.6.2 Business Overview
                     15.3.6.3 Financial Overview
                     15.3.6.4 Strategic Overview
                     15.3.6.5 SWOT Analysis
            15.3.7 QUOTIENT LIMITED
                     15.3.7.1 Company Details
                     15.3.7.2 Business Overview
                     15.3.7.3 Financial Overview
                     15.3.7.4 Strategic Overview
                     15.3.7.5 SWOT Analysis
            15.3.8 BAG Healthcare GmBH
                     15.3.8.1 Company Details
                     15.3.8.2 Business Overview
                     15.3.8.3 Financial Overview
                     15.3.8.4 Strategic Overview
                     15.3.8.5 SWOT Analysis
            15.3.9 DiaSorin S.p.A.
                     15.3.9.1 Company Details
                     15.3.9.2 Business Overview
                     15.3.9.3 Financial Overview
                     15.3.9.4 Strategic Overview
                     15.3.9.5 SWOT Analysis
            15.3.10 Hologic, Inc.
                     15.3.10.1 Company Details
                     15.3.10.2 Business Overview
                     15.3.10.3 Financial Overview
                     15.3.10.4 Strategic Overview
                     15.3.10.5 SWOT Analysis

List of Table

Table 01 Global Blood Transfusion Diagnostics Market Revenue (US$ Mn) Forecast, by Product Type, 2015–2025
Table 02 Global Blood Transfusion Diagnostics Market Revenue (US$ Mn) Forecast, by Application, 2015–2025
Table 03 Global Blood Transfusion Diagnostics Market Revenue (US$ Mn) Forecast, by Disease Screening, 2015–2025
Table 04 Global Blood Transfusion Diagnostics Market Revenue (US$ Mn) Forecast, by End-user, 2015–2025
Table 05 Global Blood Transfusion Diagnostics Market Revenue (US$ Mn) Forecast, by Region, 2015–2025
Table 06 North America Blood Transfusion Diagnostics Market Revenue (US$ Mn) Forecast, by Country, 2015–2025
Table 07 North America Blood Transfusion Diagnostics Market Revenue (US$ Mn) Forecast, by Product Type, 2015–2025
Table 08 North America Blood Transfusion Diagnostics Market Revenue (US$ Mn) Forecast, by Application, 2015–2025
Table 09 North America Blood Transfusion Diagnostics Market Revenue (US$ Mn) Forecast, by Disease Screening, 2015–2025
Table 10 North America Blood Transfusion Diagnostics Market Revenue (US$ Mn) Forecast, by End User, 2015–2025
Table 11 Europe Blood Transfusion Diagnostics Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 12 Europe Blood Transfusion Diagnostics Market Revenue (US$ Mn) Forecast, by Product Type, 2015–2025
Table 13 Europe Blood Transfusion Diagnostics Market Revenue (US$ Mn) Forecast, by Application, 2015–2025
Table 14 Europe Blood Transfusion Diagnostics Market Revenue (US$ Mn) Forecast, by Disease Screening, 2015–2025
Table 15 Europe Blood Transfusion Diagnostics Market Revenue (US$ Mn) Forecast, by End-user, 2015–2025
Table 16 Asia Pacific Blood Transfusion Diagnostics Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 17   Asia Pacific Blood Transfusion Diagnostics Market Revenue (US$ Mn) Forecast, by Product Type, 2015–2025
Table 18 Asia Pacific Blood Transfusion Diagnostics Market Revenue (US$ Mn) Forecast, by Application, 2015–2025
Table 19 Asia Pacific Blood Transfusion Diagnostics Market Revenue (US$ Mn) Forecast, by Disease Screening, 2015–2025
Table 20 Asia Pacific Blood Transfusion Diagnostics Market Revenue (US$ Mn) Forecast, by End User, 2015–2025
Table 21 Latin America Blood Transfusion Diagnostics Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 22 Latin America Blood Transfusion Diagnostics Market Revenue (US$ Mn) Forecast, by Product Type, 2015–2025
Table 23 Latin America Blood Transfusion Diagnostics Market Revenue (US$ Mn) Forecast, by Application, 2015–2025
Table 24 Latin America Blood Transfusion Diagnostics Market Revenue (US$ Mn) Forecast, by Disease Screening, 2015–2025
Table 25 Latin America Blood Transfusion Diagnostics Market Revenue (US$ Mn) Forecast, by End-user, 2015–2025
Table 26 Middle East & Africa Blood Transfusion Diagnostics Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 27 Middle East & Africa Blood Transfusion Diagnostics Market Revenue (US$ Mn) Forecast, by Product Type, 2015–2025
Table 28 Middle East & Africa Blood Transfusion Diagnostics Market Revenue (US$ Mn) Forecast, by Application, 2015–2025
Table 29 Middle East & Africa Blood Transfusion Diagnostics Market Revenue (US$ Mn) Forecast, by Disease Screening, 2015–2025
Table 30 Middle East & Africa Blood Transfusion Diagnostics Market Revenue (US$ Mn) Forecast,by End-user, 2015–2025

List of Figures

Figure 01 Global Blood Transfusion Diagnostics Market Size (US$ Mn) Forecast, 2015–2025
Figure 02 Global Blood Transfusion Diagnostics Market Value Share, by Region (2016)
Figure 04 Global Blood Transfusion Diagnostics Market Value Share, by Application (2016)
Figure 03 Global Blood Transfusion Diagnostics Market Value Share, by Product Type (2016)
Figure 05 Global Blood Transfusion Diagnostics Market Value Share, by End-user (2016)
Figure 06 Global blood transfusion diagnostics Market Value Share, by Product Type, 2017 and 2025
Figure 07 Global Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Instruments, 2015–2025
Figure 08 Global Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Kits & Reagents,
Figure 09 Global Blood Transfusion Diagnostics Market Attractiveness, by Product Type, 2017–2025
Figure 10 Global Blood Transfusion Diagnostics Market Value Share, by Application, 2017 and 2025
Figure 11 Global Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Blood Grouping, 2015–2025
Figure 12 Global Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Disease Screening,
Figure 13 Global Blood Transfusion Diagnostics Market Attractiveness, by Application, 2017–2025
Figure 14 Global Blood Transfusion Diagnostics Market Value Share, by End-user, 2017 and 2025
Figure 15 Global Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hospitals, 2015–2025
Figure 16 Global Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Blood Banks,
Figure 17 Global Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Diagnostic Laboratories, 2015–2025
Figure 18 Global Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Plasma Fractionation Companies, 2015–2025
Figure 19 Global Blood Transfusion Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2015–2025
Figure 20 Global Blood Transfusion Diagnostics Market Attractiveness, by End-user, 2017–2025
Figure 21 Global Blood Transfusion Diagnostics Market Value Share, by Region, 2017 and 2025 
Figure 22 Global Blood Transfusion Diagnostics Market Attractiveness, by Region, 2017–2025
Figure 23 North America Blood Transfusion Diagnostics Market Value Share, by Country, 2017 and 2025
Figure 24 North America Blood Transfusion Diagnostics Market Attractiveness, by Country, 2017–2025
Figure 25 North America Blood Transfusion Diagnostics Market Value Share, by Product Type, 2017 and 2025
Figure 26 North America Blood Transfusion Diagnostics Market Attractiveness, by Product Type, 2017–2025
Figure 27 North America Blood Transfusion Diagnostics Market Value Share, by Application, 2017 and 2025
Figure 28 North America Blood Transfusion Diagnostics Market Attractiveness, by Application, 2017–2025
Figure 29 North America Blood Transfusion Diagnostics Market Value Share, by End-user, 2017 and 2025
Figure 30 North America Blood Transfusion Diagnostics Market Attractiveness, by End-user, 2017–    2025
Figure 31 Europe Blood Transfusion Diagnostics Market Value Share, by Country/Sub-region, 2017 and 2025
Figure 32 Europe Blood Transfusion Diagnostics Market Attractiveness, by Country/Sub-region, 2017-2025
Figure 33 Europe Blood Transfusion Diagnostics Market Value Share, by Product Type, 2017 and 2025
Figure 34 Europe Blood Transfusion Diagnostics Market Attractiveness, by Product Type, 2017–2025
Figure 35 Europe Blood Transfusion Diagnostics Market Value Share, by Application, 2017 and 2025
Figure 36 Europe Blood Transfusion Diagnostics Market Attractiveness, by Application, 2017–2025
Figure 37 Europe Blood Transfusion Diagnostics Market Value Share, by End-user, 2017 and 2025
Figure 38 Europe Blood Transfusion Diagnostics Market Attractiveness, by End-user, 2017–2025
Figure 39 Asia Pacific Blood Transfusion Diagnostics Market Value Share, by Country/Sub-region, 2017 and 2025
Figure 40  Asia Pacific Blood Transfusion Diagnostics Market Attractiveness, by Country/Sub-region, 2017–2025
Figure 41  Asia Pacific Blood Transfusion Diagnostics Market Value Share, by Product Type, 2017 and 2025
Figure 42 Asia Pacific Blood Transfusion Diagnostics Market Attractiveness, by Product Type, 2017–2025
Figure 43 Asia Pacific Blood Transfusion Diagnostics Market Value Share, by Application, 2017 and 2025
Figure 44 Asia Pacific Blood Transfusion Diagnostics Market Attractiveness, by Application, 2017–2025
Figure 45 Asia Pacific Blood Transfusion Diagnostics Market Value Share, by End-user, 2017 and 2025
Figure 46 Asia Pacific Blood Transfusion Diagnostics Market Attractiveness, by End-user, 2017–2025
Figure 47 Latin America Blood Transfusion Diagnostics Market Value Share, by Country/Sub-region, 2017 and   2025
Figure 48 Latin America Blood Transfusion Diagnostics Market Attractiveness, by Country/Sub-Region, 2017–2025
Figure 49 Latin America Blood Transfusion Diagnostics Market Value Share, by Product Type, 2017 and 2025
Figure 50 Latin America Blood Transfusion Diagnostics Market Attractiveness, by Product Type, 2017–2025
Figure 51 Latin America Blood Transfusion Diagnostics Market Value Share, by Application, 2017 and 2025
Figure 52 Latin America Blood Transfusion Diagnostics Market Attractiveness, by Application, 2017–2025
Figure 53 Latin America Blood Transfusion Diagnostics Market Value Share, by End-user, 2017 and 2025
Figure 54 Latin America Blood Transfusion Diagnostics Market Attractiveness, by End-user, 2017–2025
Figure 55 Middle East & Africa Blood Transfusion Diagnostics Market Value Share, by Country/Sub-Region, 2017 and 2025
Figure 56 Middle East & Africa Blood Transfusion Diagnostics Market Attractiveness, by Country/Sub-region, 2017–2025
Figure 57 Middle East & Africa Blood Transfusion Diagnostics Market Value Share, by Product Type, 2017 and 2025
Figure 58 Middle East & Africa Blood Transfusion Diagnostics Market Attractiveness, by Product Type, 2017–2025
Figure 59 Middle East & Africa Blood Transfusion Diagnostics Market Value Share, by Application, 2017 and 2025
Figure 60 Middle East & Africa Blood Transfusion Diagnostics Market Attractiveness, by Application, 2017–2025
Figure 61 Middle East & Africa Blood Transfusion Diagnostics Market Value Share, by End-user, 2017 and 2025
Figure 62 Middle East & Africa Blood Transfusion Diagnostics Market Attractiveness, by End-user, 2017–2025
Figure 63 Global Blood Transfusion Diagnostics Market Share (%) & Market Share Range (%), by  Company, 2017 (Estimated)
Figure 64 Grifols S.A. Breakdown of Net Sales, by Business Segment, 2017
Figure 65 Grifols S.A. Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2017
Figure 66 DiaSorin S.p.A. Breakdown of Net Sales, by Region, 2017
Figure 67 DiaSorin S.p.A. Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2017
Figure 68 Immucor, Inc., Breakdown of Net Sales, by Product Group, 2016
Figure 69 Immucor, Inc., Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2016
Figure 70 Abbott Breakdown of Revenue (US$ Mn), by Region, 2016
Figure 71 Abbott Revenue (US$ Bn) and Y-o-Y Growth (%), 2013–2016
Figure 72 Bio-Rad Laboratories, Inc., Breakdown of Net Sales, by Region, 2016
Figure 73 Bio-Rad Laboratories, Inc., Revenue (US$ Bn) and Y-o-Y Growth (%), 2013–2016
Figure 74 Hologic, Inc., Breakdown of Net Sales, by Region, 2016
Figure 75 Hologic, Inc., Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2017
Figure 76 QUOTIENT LIMITED, Breakdown of Net Sales, by Product Group, 2017
Figure 77 QUOTIENT LIMITED, Revenue (US$ Mn) and Y-o-Y Growth (%), 2014-2017
Figure 78 F. Hoffmann-La Roche Ltd., Breakdown of Net Sales, by Business Segment, 2017
Figure 79 F. Hoffmann-La Roche Ltd., Revenue (US$ Mn) and Y-o-Y Growth (%), 2014-2017

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

294

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved